Literature DB >> 3263876

Comparative effects of fluoxetine and amitriptyline on cardiac function.

J W Upward1, J G Edwards, A Goldie, D G Waller.   

Abstract

1. The effects of fluoxetine and amitriptyline on the electrocardiogram (ECG) and systolic time intervals (STIs) were measured during a double-blind parallel-group study in depressed patients. 2. ECGs and STIs were measured after a 1 week placebo run-in, following 1 week's treatment with fluoxetine 40 mg daily or amitriptyline 100 mg daily, and then after 3 weeks' treatment with fluoxetine 60-80 mg daily or amitriptyline 150-200 mg daily. 3. Fluoxetine had no effect on the ECG or STIs at any dose. Amitriptyline 150-200 mg daily shortened the sinus cycle length by a mean of 12%, prolonged the PR interval by 8% and the QRS duration by 10%. Amitriptyline did not significantly alter the STIs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263876      PMCID: PMC1386560          DOI: 10.1111/j.1365-2125.1988.tb03397.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  ELECTROCARDIOGRAPHIC FINDINGS IN CONNECTION WITH A CLINICAL TRIAL OF CHLORPROMAZINE. WITH PARTICULAR REFERENCE TO T WAVE CHANGES AND THE DURATION OF VENTRICULAR ACTIVITY.

Authors:  H BAECKMAN; R ELOSUO
Journal:  Ann Med Intern Fenn       Date:  1964

2.  A critical review of the systolic time intervals.

Authors:  R P Lewis; S E Rittogers; W F Froester; H Boudoulas
Journal:  Circulation       Date:  1977-08       Impact factor: 29.690

3.  Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG.

Authors:  C Thorstrand
Journal:  Acta Med Scand       Date:  1976

4.  Cardiovascular complications of imipramine intoxication.

Authors:  M H Sacks; R J Bonforte; R P Laser; I Dimich
Journal:  JAMA       Date:  1968-08-19       Impact factor: 56.272

5.  The effects of psychotropic drugs on the cardiovascular system.

Authors:  S C Risch; G P Groom; D S Janowsky
Journal:  J Clin Psychiatry       Date:  1982-05       Impact factor: 4.384

Review 6.  Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

7.  A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.

Authors:  D T Wong; F P Bymaster; J S Horng; B B Molloy
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

8.  Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.

Authors:  C D Burgess; S Montgomery; J Wadsworth; P Turner
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

9.  Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.

Authors:  C D Burgess; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978       Impact factor: 4.335

10.  Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.

Authors:  R C Veith; M A Raskind; J H Caldwell; R F Barnes; G Gumbrecht; J L Ritchie
Journal:  N Engl J Med       Date:  1982-04-22       Impact factor: 91.245

View more
  12 in total

Review 1.  Should selective serotonin reuptake inhibitors be prescribed to all patients with ischemic heart disease?

Authors:  Wei Jiang; Ranga R Krishnan
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

2.  Selective serotonin reuptake inhibitors.

Authors:  J G Edwards
Journal:  BMJ       Date:  1992-06-27

Review 3.  Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology.

Authors:  M Hotopf; G Lewis; C Normand
Journal:  J Epidemiol Community Health       Date:  1997-08       Impact factor: 3.710

Review 4.  Depression and heart disease: evidence of a link, and its therapeutic implications.

Authors:  Wei Jiang; Ranga R K Krishnan; Christopher M O'Connor
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Selective serotonin reuptake inhibitors and torsade de pointes: new concepts and new directions derived from a systematic review of case reports.

Authors:  Christopher Kogut; Ericka Breden Crouse; W Victor R Vieweg; Mehrul Hasnain; Adrian Baranchuk; Geneviève C Digby; Jayanthi N Koneru; Antony Fernandez; Anand Deshmukh; Jules C Hancox; Ananda K Pandurangi
Journal:  Ther Adv Drug Saf       Date:  2013-10

6.  Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine.

Authors:  S Rajamani; L L Eckhardt; C R Valdivia; C A Klemens; B M Gillman; C L Anderson; K M Holzem; B P Delisle; B D Anson; J C Makielski; C T January
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

7.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

Review 8.  Fluoxetine versus other types of pharmacotherapy for depression.

Authors:  A Cipriani; P Brambilla; T Furukawa; J Geddes; M Gregis; M Hotopf; L Malvini; C Barbui
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

9.  Effect of paroxetine on the electrocardiogram.

Authors:  J G Edwards; A Goldie; S Papayanni-Papasthatis
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals.

Authors:  Zofia Tylutki; Aleksander Mendyk; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-06-25       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.